Get your free copy of the News Marketing Bookhere

Blockchain Transaction Record

New Brain Institute Introduces Groundbreaking Ketamine Treatment for Treatment-Resistant Depression

The New Brain Institute is at the forefront of mental health care, committed to offering innovative treatments for mental health disorders. Its focus on advanced, patient-centered therapies makes it a key player in improving mental health outcomes.

Exclusively at — Newsworthy registers every press release distributed through this service on the blockchain so that we can provide verification services and make features such as the self-hosting of press releases available to our customers. The blockchain provides an immutable record of the press releases issued by this service. Immutability gives readers the assurance that the news they are reading has not been altered from the source document that this service distributed. We have shifted the Source of Truth to the blockchain for added protection.

Moving the Source of Truth to the blockchain improves transparency and increases trust between organizations submitting news and readers.

Key Takeaways (TLDR)

  • New Brain Institute introduces SPRAVATO™, an FDA-approved ketamine nasal spray for treatment-resistant depression in adults.
  • SPRAVATO™ offers a novel ketamine-based therapy for depression, particularly beneficial for patients resistant to traditional medications.
  • With superior efficacy and minimal side effects, SPRAVATO™ from New Brain Institute is revolutionizing mental health treatment.
Transaction ID0x4620e0568210a6d86abcba3b4be291d74ba7dd8a62c2edb016f00d87836c1606
Contract Address0x1bA402ec7dDc1FAC5E85071be256f16351dF9Bb5
NWAI Digital Fingerprint1005-cfa83997cd2e8fc2d3b444eb017bd86f
Registration Timestamp2024-01-19T18:30:23+00:00

Other Recent Blockchain Registered News for New Brain Institute